GIP (22-51) human, CAS [[957470-49-4]] Preis auf Anfrage

Catalog Number: TGM-TP3711
Article Name: GIP (22-51) human, CAS [[957470-49-4]] Preis auf Anfrage
Biozol Catalog Number: TGM-TP3711
Supplier Catalog Number: TP3711
Alternative Catalog Number: TGM-TP3711-10MG,TGM-TP3711-50MG
Manufacturer: TargetMol
Category: Biochemikalien
Alternative Names: Glucose-dependent Insulinotropic Peptide (22-51) (human)
GIP (22-51) human (Glucose-dependent Insulinotropic Peptide (22-51) human) is a potent pro-atherosclerotic peptide hormone composed of 30 amino acids. It activates the NF-kappaB signaling pathway, enhances the expression of MMP-8, and induces the expression of pro-inflammatory and pro-atherogenic proteins. Additionally, it increases intracellular free Ca2+ levels in THP-1 induced macrophages. GIP (22-51) human is useful for atherosclerosis research.
Molecular Weight: 3181.56
CAS Number: [957470-49-4]
Formula: C140H226N44O41
Target: MMP|||NF-kappaB|||Calcium Channel
TP3711